GlassScriptPhysician profile
Stephanie Roy
NPI 1356735542
$3,654.39
in general payments reported to CMS, 2019-2025
35 companies · $492 in 2025
The $492 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $400 · 2022: $1,615 · 2023: $639 · 2024: $507 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Entertainment: $15.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.01 |
| Entertainment | $15.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,143.62 | 2022 | |
| Abbvie INC. | $254.31 | 2021-2023 | Lo Loestrin Fe |
| Novo Nordisk INC | $197.80 | 2022-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $194.97 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $181.26 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $156.00 | 2021-2025 | Solosec, Phexx, Phexxi |
| Meditrina | $140.67 | 2023 | |
| Sage Therapeutics, LLC | $137.75 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $133.89 | 2021-2025 | |
| Myovant Sciences INC. | $129.25 | 2021-2022 | |
| Shield Therapeutics INC | $118.54 | 2022-2025 | |
| Exeltis, USA INC. | $115.18 | 2021-2025 | Slynd |
| Pfizer INC. | $112.16 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $56.41 | 2023-2024 | Exparel, Iovera, Zilretta |
| Stryker Corporation | $52.32 | 2025 | Npseal |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $51.78 | 2022-2024 | Pico 7 |
| Avion Pharmaceuticals | $50.53 | 2022-2023 | Balcoltra |
| Idorsia Pharmaceuticals US INC | $44.71 | 2023 | Quviviq |
| Davol INC. | $42.71 | 2023 | Arista Ah Flexitip |
| Astellas Pharma US INC | $34.04 | 2023 | Veozah |
| Ethicon US, LLC | $30.97 | 2021-2025 | Surgiflo Hemostatic Matrix, Ethicon, Vistaseal |
| Supernus Pharmaceuticals, INC. | $28.00 | 2025 | Qelbree |
| Teleflex LLC | $27.80 | 2025 | Quikclot |
| Medtronic, INC. | $24.72 | 2023 | V-Loc 180 |
| Mylan Pharmaceuticals INC. | $24.01 | 2022 | |
| Agile Therapeutics, INC. | $21.38 | 2023 | Twirla |
| Organon LLC | $20.73 | 2021 | |
| Coopersurgical, INC. | $19.87 | 2024 | Paragard T 380a |
| Millicent US INC | $17.14 | 2025 | Femlyv, Intrarosa |
| Merck Sharp & Dohme LLC | $16.74 | 2022 | |
| Dexcom, INC. | $16.60 | 2023 | Dexcom G6 Transmitter |
| Gynesonics, INC. | $16.56 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Argentum Medical | $15.53 | 2025 | |
| Innovation Technologies INC | $13.84 | 2024 | Irrisept |
| Channel Medsystems, INC. | $12.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.